Dynavax Technologies | Vendas



Sales Alterar Data
AbbVie USD 13.34B 1.76B 2025-03
Adma Biologics USD 117.55M 2.29M 2024-12
Amgen USD 8.15B 936M 2025-03
AstraZeneca USD 13.59B 1.3B 2025-03
Biogen USD 2.43B 24.7M 2025-03
BioMarin Pharmaceutical USD 745M 2.31M 2025-03
Bristol-Myers Squibb USD 11.2B 1.14B 2025-03
Dynavax Technologies USD 65M 7.03M 2025-03
Gilead Sciences USD 6.67B 899M 2025-03
Glaxosmithkline GBP 8.12B 105M 2024-12
Merck USD 15.53B 94M 2025-03
Neurocrine Biosciences USD 572.6M 55.1M 2025-03
Novartis USD 13.15B 330M 2024-12
Pfizer USD 13.72B 4.04B 2025-03
Regeneron Pharmaceuticals USD 3.03B 760M 2025-03
Roche Holding CHF 31.64B 883M 2024-12
Sarepta Therapeutics USD 774.9M 116.49M 2025-03
TG Therapeutics USD 119.7M 11.51M 2025-03
Vertex Pharmaceuticals USD 2.77B 142M 2025-03



Dynavax Technologies Vendas - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.